Compounds > clodronic acid
Page last updated: 2024-08-22

clodronic acid and Carcinoma, Hepatocellular

clodronic acid has been researched along with Carcinoma, Hepatocellular in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Chen, J; Fang, Y; Gu, L; Ji, K; Pan, M; Tian, S1
Han, Z; Hou, X; Lu, Y; Sheng, D; Sun, G; Wang, X; Wei, L; Yang, X; Zhang, H; Zhang, L1
Chen, Y; Ma, C; Shao, B; Zhang, F; Zhou, Y1
Kong, LQ; Sun, HC; Tang, ZY; Wang, L; Wu, WZ; Xiong, YQ; Xu, HX; Zhang, W; Zhu, XD; Zhuang, PY1

Other Studies

4 other study(ies) available for clodronic acid and Carcinoma, Hepatocellular

ArticleYear
HMGA1 Promotes Macrophage Recruitment via Activation of NF-
    Journal of immunology research, 2022, Volume: 2022

    Topics: Animals; Carcinoma, Hepatocellular; Chemokine CCL2; Clodronic Acid; HMGA1a Protein; Humans; Ligands; Liposomes; Liver Neoplasms; Macrophages; NF-kappa B; Tumor Microenvironment

2022
Doxorubicin-liposome combined with clodronate-liposome inhibits hepatocellular carcinoma through the depletion of macrophages and tumor cells.
    International journal of pharmaceutics, 2022, Dec-15, Volume: 629

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Clodronic Acid; Doxorubicin; Liposomes; Liver Neoplasms; Macrophages; Rats; Tumor Microenvironment

2022
Liposomal clodronate combined with Cisplatin or Sorafenib inhibits hepatocellular carcinoma cell proliferation, migration and invasion by suppressing FOXQ1 expression.
    Cellular and molecular biology (Noisy-le-Grand, France), 2020, Apr-20, Volume: 66, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Cisplatin; Clodronic Acid; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liposomes; Liver Neoplasms; Neoplasm Invasiveness; RNA, Messenger; Sorafenib

2020
Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Jul-01, Volume: 16, Issue:13

    Topics: Angiogenesis Inhibitors; Animals; Benzenesulfonates; Carcinoma, Hepatocellular; Cell Line, Tumor; Clodronic Acid; Diphosphonates; Drug Therapy, Combination; Humans; Imidazoles; Liposomes; Liver Neoplasms, Experimental; Lung Neoplasms; Macrophages; Male; Mice; Mice, Nude; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Xenograft Model Antitumor Assays; Zoledronic Acid

2010